Julia Jeck
Overview
Explore the profile of Julia Jeck including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
25
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stemler J, Yeghiazaryan L, Stephan C, Mohn K, Carcas-Sansuan A, Rodriguez E, et al.
Int J Infect Dis
. 2024 Jul;
146:107161.
PMID: 38992789
Objectives: To assess the safety and immunogenicity of a fourth vaccination (second booster) in individuals aged ≥75 years. Methods: Participants were randomized to BNT162b2 (Comirnaty, 30 µg) or messenger RNA...
2.
Wickmann A, Kurte M, Jeck J, Camacho L, Klinkhammer D, Kron F, et al.
Cost Eff Resour Alloc
. 2024 Mar;
22(1):21.
PMID: 38459569
Background: Triple-negative breast cancer (TNBC) is responsible for 10-20% cases of breast cancer and is resulting in rising healthcare costs. Thus, health-economic evaluations are needed to relate clinical outcomes and...
3.
Jeck J, Jakobs F, Kurte M, Cornely O, Kron F
JAC Antimicrob Resist
. 2023 Jun;
5(3):dlad079.
PMID: 37342199
Objective: species are responsible for fungal diseases and the development of nosocomial bloodstream infections. Treatment is resource-intensive and economically challenging for healthcare systems. Cost analyses of drugs against candidiasis, such...
4.
Jeck J, Wingen-Heimann S, Jakobs F, Kron A, Franz J, Cornely O, et al.
Mycoses
. 2023 Jan;
66(5):405-411.
PMID: 36670539
Background: Invasive fungal diseases (IFD) are life-threatening and demand timely and appropriate treatment. Research showed that isavuconazole treatment positively affects clinical outcome and length of hospital stay (LOS). Objectives: The...
5.
Jeck J, Wingen-Heimann S, Jakobs F, Franz J, Baltin C, Kron A, et al.
Healthcare (Basel)
. 2022 Dec;
10(12).
PMID: 36554068
Multidrug-resistant Gram-negative bacteria (MDR-GNB) cause serious infections and aggravate disease progression. Last resort antibiotics are effective against MDR-GNB and are reimbursed by flat rates based on German diagnosis-related groups (G-DRG)....
6.
Jakobs F, Jeck J, Ahmadi P, Kron A, Kron F
Cost Eff Resour Alloc
. 2022 Dec;
20(1):67.
PMID: 36503527
Background: In the past decades, highly innovative treatments in the field of diffuse large B-cell lymphoma (DLBCL) became available in clinical practice. The aim of this study was to assess...
7.
Wingen S, Jeck J, Schroeder D, Wingen-Heimann S, Drost R, Bottiger B
Eur J Anaesthesiol
. 2021 Dec;
39(8):711-719.
PMID: 34860715
Background: Training schoolchildren in resuscitation seems to improve rates of resuscitation by bystanders. Leading medical societies recommend comprehensive resuscitation education in schools. To date, no widespread implementation within the European...
8.
Jeck J, Jakobs F, Kron A, Cornely O, Kron F
J Antimicrob Chemother
. 2021 Dec;
77(3):753-757.
PMID: 34849943
Objectives: Internationally, healthcare systems are confronted by an ever-increasing scarcity of medical resources due to the ongoing novel coronavirus disease 2019 (COVID-19) pandemic. The aim of this study was to...
9.
Jakobs F, Wingen-Heimann S, Jeck J, Kron A, Cornely O, Kron F
BMC Health Serv Res
. 2021 Sep;
21(1):939.
PMID: 34496836
Background: Clostridioides difficile infection (CDI) is one of the leading nosocomial infections, resulting in increased hospital length of stay and additional treatment costs. Bezlotoxumab, the first monoclonal antibody against CDI,...
10.
Jeck J, Jakobs F, Kron A, Franz J, Cornely O, Kron F
Infection
. 2021 Aug;
50(1):191-201.
PMID: 34406606
Purpose: First detected in China in 2019, the novel coronavirus disease (COVID-19) has rapidly spread globally. Since then, healthcare systems are exposed to major challenges due to scarce personnel and...